Camp4 Therapeutics annual free cash flow
2022
2023
2024
2025
Camp4 Therapeutics Free Cash Flow (FCF) History (CAMP)
Camp4 Therapeutics reported −$29.8M in free cash flow for fiscal 2025, an increase of $16.2M from the previous fiscal year, with a free cash flow margin of −852.83%.
View full Camp4 Therapeutics company overviewCamp4 Therapeutics free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | −$29.8M | $16.2M | — | −852.83% |
| 2024 | 2024-12-31 | −$46.0M | −$1.2M | — | −7055.67% |
| 2023 | 2023-12-31 | −$44.8M | −$2.3M | — | −12809.43% |
| 2022 | 2022-12-31 | −$42.6M | — | — | — |
Camp4 Therapeutics quarterly free cash flow
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$12.8M | −$2.5M | — | −720.35% |
| Q1 2026 | 2026-03-31 | −$11.0M | $3.6M | — | −848.61% |
| Q4 2025 | 2025-12-31 | $6.3M | $17.8M | — | +1808.33% |
| Q3 2025 | 2025-09-30 | −$11.2M | −$1.5M | — | −1410.94% |
| Q2 2025 | 2025-06-30 | −$10.3M | $3.3M | — | −690.92% |
| Q1 2025 | 2025-03-31 | −$14.6M | −$3.4M | — | −1697.55% |
| Q4 2024 | 2024-12-31 | −$11.6M | — | — | −1771.63% |
| Q3 2024 | 2024-09-30 | −$9.7M | — | — | — |
| Q2 2024 | 2024-06-30 | −$13.6M | — | — | — |
| Q1 2024 | 2024-03-31 | −$11.2M | — | — | — |
Camp4 Therapeutics free cash flow growth trends
Camp4 Therapeutics's latest reported quarter, Q2 2026, generated −$12.8M in free cash flow, a decrease of $2.5M year over year.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Camp4 Therapeutics source filings ↗Community posts
CAMP4 receives UK authorization for its first SYNGAP1 clinical study
CAMP4 Therapeutics ($CAMP) received UK authorization to include sites in its global Phase 1/2 study of CMP002, an investigational treatment for SYNGAP1-related disorder. The decision follows earlier clearances in Australia and Argentina, wh ...